This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Book Review

Bipolar Medications : Mechanisms of Action

Victor I. Reus

Published: July 1, 2001

Article Abstract

From our regular book review column.

Mogens Schou, when recently asked why he had spent almost his entire scientific life focused on lithium, stated that there was so much to find out about it he saw no reason to turn to other topics. Although over 50 years have elapsed since John Cade’s initial observations, the mechanism of lithium’s remarkably specific therapeutic effects in bipolar mood disorder has remained elusive. Recently, however, there has been a convergence of evidence that suggests that a breakthrough in understanding may be imminent. The clinical usage of novel anticonvulsant drugs such as lamotrigine, gabapentin, and topiramate, among others, has kindled a resurgent effort to identify biological actions that might link these agents to lithium, valproic acid, and carbamazepine and possibly illuminate the underlying pathophysiology of manic-depressive illness.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 62

Quick Links: